Use of complementary medications among older adults with cancer

Ronald Maggiore, Cary P. Gross, Kayo Togawa, William P. Tew, Supriya G. Mohile, Cynthia Owusu, Heidi D. Klepin, Stuart M. Lichtman, Ajeet Gajra, Rupal Ramani, Vani Katheria, Shira M. Klapper, Kurt Hansen, Arti Hurria

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

BACKGROUND: Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer. METHODS: The prevalence of complementary medication use (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) was evaluated in a cohort of adults aged ≥yen;65 years who were about to start chemotherapy for their cancer. The associations between complementary medication use and patient characteristics (sociodemographics; comorbidities; and functional, nutritional, psychological, and cognitive status), medication use (number of medications and concurrent vitamin use), and cancer characteristics (type and stage) were analyzed. RESULTS: The cohort included 545 patients (mean age, 73 years; range, 65-91 years; 52% women) with cancer (61% stage IV). Seventeen percent of these patients (N = 93) reported using ≥yen;1 complementary medication; the mean number of complementary medications among users was 2 (range, 1-10 medications). Complementary medication use was associated with 1) earlier cancer stage (29% had stage I-II disease vs 17% with stage III-IV disease; odds ratio [OR], 2.05; 95% confidence interval [CI], 1.21-3.49) and 2) less impairment with instrumental activities of daily living (OR, 1.39; 95% CI, 1.12-1.73). CONCLUSIONS: Complementary medication use was reported by 17% of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status. Further studies are needed to determine the association between complementary medication use and cancer outcomes among older adults.

Original languageEnglish (US)
Pages (from-to)4815-4823
Number of pages9
JournalCancer
Volume118
Issue number19
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Neoplasms
Vitamins
Odds Ratio
Confidence Intervals
Drug Therapy
Activities of Daily Living
Dietary Supplements
Minerals
Comorbidity
Psychology
Therapeutics

Keywords

  • cancer. chemotherapy
  • complementary medicine
  • herbals
  • older adults

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Maggiore, R., Gross, C. P., Togawa, K., Tew, W. P., Mohile, S. G., Owusu, C., ... Hurria, A. (2012). Use of complementary medications among older adults with cancer. Cancer, 118(19), 4815-4823. https://doi.org/10.1002/cncr.27427

Use of complementary medications among older adults with cancer. / Maggiore, Ronald; Gross, Cary P.; Togawa, Kayo; Tew, William P.; Mohile, Supriya G.; Owusu, Cynthia; Klepin, Heidi D.; Lichtman, Stuart M.; Gajra, Ajeet; Ramani, Rupal; Katheria, Vani; Klapper, Shira M.; Hansen, Kurt; Hurria, Arti.

In: Cancer, Vol. 118, No. 19, 01.10.2012, p. 4815-4823.

Research output: Contribution to journalArticle

Maggiore, R, Gross, CP, Togawa, K, Tew, WP, Mohile, SG, Owusu, C, Klepin, HD, Lichtman, SM, Gajra, A, Ramani, R, Katheria, V, Klapper, SM, Hansen, K & Hurria, A 2012, 'Use of complementary medications among older adults with cancer', Cancer, vol. 118, no. 19, pp. 4815-4823. https://doi.org/10.1002/cncr.27427
Maggiore R, Gross CP, Togawa K, Tew WP, Mohile SG, Owusu C et al. Use of complementary medications among older adults with cancer. Cancer. 2012 Oct 1;118(19):4815-4823. https://doi.org/10.1002/cncr.27427
Maggiore, Ronald ; Gross, Cary P. ; Togawa, Kayo ; Tew, William P. ; Mohile, Supriya G. ; Owusu, Cynthia ; Klepin, Heidi D. ; Lichtman, Stuart M. ; Gajra, Ajeet ; Ramani, Rupal ; Katheria, Vani ; Klapper, Shira M. ; Hansen, Kurt ; Hurria, Arti. / Use of complementary medications among older adults with cancer. In: Cancer. 2012 ; Vol. 118, No. 19. pp. 4815-4823.
@article{6881c8eba9fd45cf99768ac32707bf2c,
title = "Use of complementary medications among older adults with cancer",
abstract = "BACKGROUND: Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer. METHODS: The prevalence of complementary medication use (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) was evaluated in a cohort of adults aged ≥yen;65 years who were about to start chemotherapy for their cancer. The associations between complementary medication use and patient characteristics (sociodemographics; comorbidities; and functional, nutritional, psychological, and cognitive status), medication use (number of medications and concurrent vitamin use), and cancer characteristics (type and stage) were analyzed. RESULTS: The cohort included 545 patients (mean age, 73 years; range, 65-91 years; 52{\%} women) with cancer (61{\%} stage IV). Seventeen percent of these patients (N = 93) reported using ≥yen;1 complementary medication; the mean number of complementary medications among users was 2 (range, 1-10 medications). Complementary medication use was associated with 1) earlier cancer stage (29{\%} had stage I-II disease vs 17{\%} with stage III-IV disease; odds ratio [OR], 2.05; 95{\%} confidence interval [CI], 1.21-3.49) and 2) less impairment with instrumental activities of daily living (OR, 1.39; 95{\%} CI, 1.12-1.73). CONCLUSIONS: Complementary medication use was reported by 17{\%} of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status. Further studies are needed to determine the association between complementary medication use and cancer outcomes among older adults.",
keywords = "cancer. chemotherapy, complementary medicine, herbals, older adults",
author = "Ronald Maggiore and Gross, {Cary P.} and Kayo Togawa and Tew, {William P.} and Mohile, {Supriya G.} and Cynthia Owusu and Klepin, {Heidi D.} and Lichtman, {Stuart M.} and Ajeet Gajra and Rupal Ramani and Vani Katheria and Klapper, {Shira M.} and Kurt Hansen and Arti Hurria",
year = "2012",
month = "10",
day = "1",
doi = "10.1002/cncr.27427",
language = "English (US)",
volume = "118",
pages = "4815--4823",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "19",

}

TY - JOUR

T1 - Use of complementary medications among older adults with cancer

AU - Maggiore, Ronald

AU - Gross, Cary P.

AU - Togawa, Kayo

AU - Tew, William P.

AU - Mohile, Supriya G.

AU - Owusu, Cynthia

AU - Klepin, Heidi D.

AU - Lichtman, Stuart M.

AU - Gajra, Ajeet

AU - Ramani, Rupal

AU - Katheria, Vani

AU - Klapper, Shira M.

AU - Hansen, Kurt

AU - Hurria, Arti

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BACKGROUND: Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer. METHODS: The prevalence of complementary medication use (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) was evaluated in a cohort of adults aged ≥yen;65 years who were about to start chemotherapy for their cancer. The associations between complementary medication use and patient characteristics (sociodemographics; comorbidities; and functional, nutritional, psychological, and cognitive status), medication use (number of medications and concurrent vitamin use), and cancer characteristics (type and stage) were analyzed. RESULTS: The cohort included 545 patients (mean age, 73 years; range, 65-91 years; 52% women) with cancer (61% stage IV). Seventeen percent of these patients (N = 93) reported using ≥yen;1 complementary medication; the mean number of complementary medications among users was 2 (range, 1-10 medications). Complementary medication use was associated with 1) earlier cancer stage (29% had stage I-II disease vs 17% with stage III-IV disease; odds ratio [OR], 2.05; 95% confidence interval [CI], 1.21-3.49) and 2) less impairment with instrumental activities of daily living (OR, 1.39; 95% CI, 1.12-1.73). CONCLUSIONS: Complementary medication use was reported by 17% of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status. Further studies are needed to determine the association between complementary medication use and cancer outcomes among older adults.

AB - BACKGROUND: Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer. METHODS: The prevalence of complementary medication use (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) was evaluated in a cohort of adults aged ≥yen;65 years who were about to start chemotherapy for their cancer. The associations between complementary medication use and patient characteristics (sociodemographics; comorbidities; and functional, nutritional, psychological, and cognitive status), medication use (number of medications and concurrent vitamin use), and cancer characteristics (type and stage) were analyzed. RESULTS: The cohort included 545 patients (mean age, 73 years; range, 65-91 years; 52% women) with cancer (61% stage IV). Seventeen percent of these patients (N = 93) reported using ≥yen;1 complementary medication; the mean number of complementary medications among users was 2 (range, 1-10 medications). Complementary medication use was associated with 1) earlier cancer stage (29% had stage I-II disease vs 17% with stage III-IV disease; odds ratio [OR], 2.05; 95% confidence interval [CI], 1.21-3.49) and 2) less impairment with instrumental activities of daily living (OR, 1.39; 95% CI, 1.12-1.73). CONCLUSIONS: Complementary medication use was reported by 17% of older adults with cancer and was more common among those who had less advanced disease (i.e., those receiving adjuvant, potentially curative treatment) and higher functional status. Further studies are needed to determine the association between complementary medication use and cancer outcomes among older adults.

KW - cancer. chemotherapy

KW - complementary medicine

KW - herbals

KW - older adults

UR - http://www.scopus.com/inward/record.url?scp=84866489453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866489453&partnerID=8YFLogxK

U2 - 10.1002/cncr.27427

DO - 10.1002/cncr.27427

M3 - Article

C2 - 22359348

AN - SCOPUS:84866489453

VL - 118

SP - 4815

EP - 4823

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 19

ER -